1 |
Ryu, S. Y., M. H. Oak, S. K. Yoon, D. I. Cho, G. S. Yoo, T. S. Kim, and K. M. Kim. 2000. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med. 66, 358-360.
DOI
|
2 |
Samama, C. M. and N. Rosencher. 2009. New oral anticoagulant agent: do not walk out of the line. Annales Francaises d'Anesthesie et de Reanimation 28, 836-837.
DOI
ScienceOn
|
3 |
Shimano, T., M. Mizuno, H. Okamoto, and I. Adachi. 1956. Studies on triterpenoids. Ⅸ. On the new component of Prunella, ursolic acid. J Pharm Soc Jpn 76, 974-975.
|
4 |
Sohn, H. Y., K. H. Son, C. S. Kwon, and G. S. Kwon. 2007. A compound comprising 2α-hydroxy-oleanolic acid for prevention and control of thrombosis. Korea patent 1007040030000.
|
5 |
Tanachatchairatana, T., J. B. Bremner, R. Chokchaisiri, and A. Suksamrarn. 2008. Antimycobacterial activity of cinnamate-based esters of the triterpenes betulinic, oleanolic and ursolic acids. Chem. Pharm. Bull. 56, 194-198.
DOI
|
6 |
Xu, H. X., S. H. Lee, S. F. Lee, R. L White, and J. Blay. 1999. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res. 44, 43-54.
DOI
|
7 |
Yang, S. A., N. K. Im, and I. S. Lee. 2007. Effect of methanolic extract from salvia miltiorrhiza Bunge on in vitro antithrombotic and antioxidative activities. Korean J. Food Sci. Technol. 39, 83-87.
|
8 |
Yim, E. K., M. J. Lee, K. H. Lee, S. J. Um, and J. S. Park. 2006. Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinomacell lines. Int. J. Gynecol. Cancer 16, 2023-2031.
DOI
|
9 |
Kageyama, S., M. Kurokawa, and K. Shiraki. 2000. Extract of Prunella vulgaris spikes inhibits HIV replication at reverse transcription in vitro and can be absorbed from intes-tine in vivo. Chem. Chemother.11, 157-164.
|
10 |
Kim, Y. W. and D. C. Kim. 1999. Evaluation of thrombolytic effect of streptokinase-dextran conjugate in a rat model of arterial thrombosis. J. Korean Pharm. Sci. 29, 211-216.
과학기술학회마을
|
11 |
Kojima, H. and H. Ogura. 1986. Triterpenoids from Prunella vulgaris. Phytochemistry 25, 729-733.
DOI
|
12 |
Lam, T. L., M. L. Lam, T. K. Au, D. T. Ip, T. B. Ng, W. P. Fong, and D. C. Wan. 2002. A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs. J. Life Sci. 67, 2889-2896.
|
13 |
Lamaison, J. L., C. Petitjean-Freytet, and A. Carnat. 1991. Medicinal lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Pharm. Acta. Helv. 66, 185-188.
|
14 |
Lee, H. and J. Y. Lin. 1988. Anti mutagenic activity of extracts from anticancer drugs in medicine. Mutat. Res. 204, 229-234.
DOI
|
15 |
Lee, H. S. 1995. How safe is the readministration of streptokinase? Drug Safety 13, 76-80.
DOI
|
16 |
Liu, F. and T. B. Ng. 2000. Anti oxidative and free radical scavenging activities of selected medicinal herbs. J. Life Sci. 166, 725-735.
|
17 |
Liu, J. 1995. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49, 57-68.
DOI
|
18 |
Liu, S., S. Jiang, Z. Wu, L. Lv, J. Zhang, Z. Zhu, and S. Wu. 2002. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte. Life Sci. 71, 1779-1791.
DOI
|
19 |
Birk, S., C. Kruuse, and K. A. Peter. 2006. The headache-inducing effect of cilostazol in human volunteers. Cephalagia 26, 1304-1309.
DOI
|
20 |
Au, T. K., T. L. Lam, T. B. Ng, W. P. Fong, and D. C. Wan. 2001. A comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs. J. Life Sci. 68, 1687-1694.
DOI
|
21 |
De Meyer, S. F., K. Vanhooelbbeke, and K. l. Broos. 2008. Antiplatelet drugs. British J. Haematology 142, 515-528.
DOI
|
22 |
Fan, J., Y. Zhang, X. Chang, B. Zhang, D. Jiang, M. Saito, and Z. Li. 2009. Antithrombotic and fibrinolytic activities of methanolic extract of aged sorghum vinegar. J. Agric. Food Chem. 57, 8683-8687.
DOI
|
23 |
Francescone, S. and J. L. Halperin. 2008. "Triple theraphy" or triple threat?: balancing the risks of antithrombotic theraphy for patients with atrial fibrillation and coronary stents. J. Am. Coll. Cardiol. 51, 826-827.
DOI
|
24 |
Fontanay, S., M. Grare, J. Mayer, C. Finance, and R. E. Duval. 2008. Ursolic, oleanolic and betulinic acids: Antibacterial spectra and selectivity indexs. J. Ethnopharmacol. 120, 272-276.
DOI
|
25 |
Johnson, S. 2008. Known knowns and known unknowns: Risks associated with combination antithrombotic theraphy. Thromb. Res. 23, S7-S11.
|
26 |
Jung, Y. B., K. J. Roh, J. A. Jung, K. Jung, H. Yoo, Y. B. Cho, W. J. Kwak, D. K. Kim, K. H. Kim, and C. K. Han. 2001. Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled study. Am. J. Chin. Med. 29, 485-491.
DOI
|